We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.41%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2B
AUM Growth
-$231M
(-10%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-10.69%
Top 10 Holdings %
Top 10 Hldgs %
6.82%
Holding
1,904
New
580
Increased
368
Reduced
360
Closed
591
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$13.5M |
| 2 |
Amgen
AMGN
|
+$13.4M |
| 3 |
Charter Communications
CHTR
|
+$12M |
| 4 |
Amazon
AMZN
|
+$11M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$20M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$19.3M |
| 3 |
Pfizer
PFE
|
+$19.2M |
| 4 |
Alkermes
ALKS
|
+$14.8M |
| 5 |
Visa
V
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.12% |
| 2 | Healthcare | 11.46% |
| 3 | Technology | 11.32% |
| 4 | Industrials | 11.2% |
| 5 | Materials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Rayonier
RYN
$6.52B
| $218K | 0.01% |
9,191
-28,328
| -76% | -$650K |
|
|
CTRL
1077
DELISTED
Control4 Corporation
CTRL
| $217K | 0.01% |
26,708
-20,870
| -44% | -$162K |
|
|
NSU
1078
DELISTED
Nevsun Resources Ltd.
NSU
| $217K | 0.01% |
73,866
-3,985
| -5% | -$13.2K |
|
1079
Norwegian Cruise Line
NCLH
$9.2B
| $216K | 0.01% |
5,443
-95,000
| -95% | -$4.53M |
|
|
RT
1080
DELISTED
Ruby Tuesday Georgia
RT
| $216K | 0.01% |
+59,889
| New | +$253K |
|
1081
Applied Optoelectronics
AAOI
$7.85B
| $215K | 0.01% |
+19,321
| New | +$218K |
|
|
BXE
1082
DELISTED
Bellatrix Exploration Ltd.
BXE
| $215K | 0.01% |
+43,561
| New | +$230K |
|
1083
Hanmi Financial
HAFC
$942M
| $214K | 0.01% |
+9,148
| New | +$210K |
|
1084
Ovintiv
OVV
$16.6B
| $213K | 0.01% |
5,484
-47,900
| -90% | -$1.75M |
|
|
JONE
1085
DELISTED
Jones Energy, Inc.
JONE
| $213K | 0.01% |
2,823
-370
| -12% | -$28K |
|
|
CASC
1086
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $213K | 0.01% |
37,712
+22,413
| +146% | +$152K |
|
|
INN
1087
Summit Hotel Properties
INN
$748M
| $212K | 0.01% |
16,033
-2,848
| -15% | -$34K |
|
|
TVTY
1088
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $212K | 0.01% |
18,414
-27,000
| -59% | -$316K |
|
|
GAU
1089
Galiano Gold
GAU
$478M
| $211K | 0.01% |
+55,411
| New | +$183K |
|
1090
RingCentral
RNG
$4.5B
| $211K | 0.01% |
+10,748
| New | +$203K |
|
1091
PLDT
PHI
$4.26B
| $210K | 0.01% |
+4,732
| New | +$189K |
|
|
INFI
1092
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $210K | 0.01% |
+158,507
| New | +$741K |
|
1093
LSI Industries
LYTS
$854M
| $209K | 0.01% |
18,915
-13,700
| -42% | -$163K |
|
1094
Mistras Group
MG
$495M
| $209K | 0.01% |
8,769
+300
| +4% | +$7.33K |
|
|
CIVI
1095
DELISTED
Civitas Solutions, Inc.
CIVI
| $209K | 0.01% |
+10,071
| New | +$199K |
|
|
EQY
1096
DELISTED
Equity One
EQY
| $209K | 0.01% |
6,512
-5,000
| -43% | -$146K |
|
1097
Fortune Brands Innovations
FBIN
$6.14B
| $208K | 0.01% |
+4,218
| New | +$206K |
|
|
DERM
1098
DELISTED
Dermira, Inc.
DERM
| $207K | 0.01% |
+7,106
| New | +$196K |
|
1099
B2Gold
BTG
$5.16B
| $206K | 0.01% |
+82,123
| New | +$166K |
|
1100
PDS Biotechnology
PDSB
$38.7M
| $206K | 0.01% |
+1,020
| New | +$180K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, A.R.T. Advisors held 1,904 positions worth $2B, down 10% from $2.24B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
A.R.T. Advisors withdrew a net $214M in Q2 2016, closing 591 positions and reducing 360 holdings. Its most notable exit was Johnson & Johnson, an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
Against the trend, A.R.T. Advisors opened a new position in Mastercard worth $12.4M.
- A.R.T. Advisors's largest Q2 2016 buy was Mastercard: 141,390 shares worth $12.4M.
- A.R.T. Advisors added most to Paramount Global Class B in Q2 2016, an estimated $8.3M increase.
- A.R.T. Advisors's biggest Q2 2016 reduction was Visa, cutting an estimated $12.8M.
- A.R.T. Advisors fully exited Johnson & Johnson in Q2 2016, selling an estimated $20M.
- A.R.T. Advisors's ten largest holdings make up 6.8% of its $2B portfolio in Q2 2016.
- A.R.T. Advisors opened 580 new positions and closed 591 in Q2 2016.
- A.R.T. Advisors's portfolio value fell 10% quarter-over-quarter to $2B.
Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.